🕒 Tuesday 3 February 2026 Tue, 3 Feb 2026

FMR Resources has extended its latest diamond drillhole at the Llahuin Project’s Target C, intersecting visual copper and molybdenum mineralisation linked to a key geophysical anomaly. This marks a promising step towards pinpointing the core of a significant porphyry copper-gold-molybdenum system.

Nimy Resources reveals a significant extension to its Block 3 gallium deposit in Western Australia, with a high-resolution magnetic survey indicating a 3.5km strike beyond the current resource boundary. The company is also advancing metallurgical test work and seeking federal funding to support development.

Barton Gold Holdings has kicked off its 2026 drilling campaign at the Tunkillia Gold Project, aiming to secure Ore Reserves, complete a pre-feasibility study, and lodge a Mining Lease application by the end of the year.

Sparc Technologies and the Australian Institute for Machine Learning are developing AI-driven software to transform protective coatings corrosion assessment, promising faster, more accurate results for a global market of testing labs.

Xpedra Resources has appointed mining veteran Scott Funston as Managing Director, aligning leadership with the launch of its maiden drilling program at the promising Springfield Gold Deposit in NSW.

Imricor Medical Systems has welcomed Oklahoma Heart Institute as the fourth U.S. site in its pivotal VISABL-AFL clinical trial, accelerating patient recruitment and the FDA approval pathway for its MRI-guided cardiac ablation technology.

Memphasys has lodged regulatory submissions for its Felix™ System in Australia and India, following CE Mark approval, while progressing UK market entry under the CE Mark transition framework.

Catalina Resources has verified a copper-rich Volcanogenic Massive Sulphide system at its Breakaway Dam Project in Western Australia, prompting a substantial follow-up drilling program. Concurrently, gold mineralisation continuity is confirmed at the Leghorn Prospect within the Evanston Project.

Aroa Biosurgery’s latest business update reveals promising clinical outcomes from its Myriad trauma study and evolving reimbursement policies that could reshape its market position. The company also projects solid revenue growth for FY26, supported by strategic commercial initiatives.

Rhythm Biosciences has secured a multi-year commercial manufacturing agreement with US-based Quansys Biosciences to produce ColoSTAT® reagent kits, paving the way for broader market rollout of its colorectal cancer diagnostic test.

Aroa Biosurgery reaffirms strong FY26 guidance, buoyed by favourable US Medicare reimbursement for Symphony and promising trauma study results for Myriad.

Resolution Minerals has taken a significant step towards expanding its footprint in the US capital markets by lodging a registration statement with the SEC and launching an ADR facility, while divesting a non-core Alaskan asset to focus on key US projects.

Xero Limited has outlined a bold AI strategy and detailed the integration of Melio to accelerate its US market growth, supported by new financial disclosures and a clear path to profitability.

Xero Limited reveals new AI product demonstrations and updates on Melio’s integration, reaffirming ambitious US growth and FY28 revenue targets.

Galileo Mining’s recent drilling at its Norseman project has confirmed promising palladium-platinum-gold mineralisation near surface, with a funded diamond drilling program poised to test for deeper extensions beneath the Callisto deposit.

Credit Corp Group posted a steady first half with 4% revenue growth and flat net profit, setting the stage for a robust second half driven by increased lending and debt buying investments.

Credit Corp delivers steady H1 FY26 results with robust US collections and record lending volumes, while pursuing a strategic acquisition to boost its consumer finance footprint.

Credit Corp Group Limited reported a steady half-year profit with a 4% revenue rise, driven by strong US collections and record lending volumes, while advancing its UK presence through a strategic acquisition.

Mount Hope Mining (MHM) showcased strong drilling outcomes at its Mt Solitary gold project, reinforcing its strategic foothold in the prolific southern Cobar Basin. The company is advancing exploration with a clear pathway to resource definition and regional consolidation.

5E Advanced Materials is raising up to $36 million through a stock offering to fund the development of its Fort Cady boron and lithium project in California. The capital raise comes amid ongoing concerns about the company’s ability to continue as a going concern without further financing.

Premier1 Lithium has kicked off a significant reverse circulation drilling campaign at its Mt Kersey gold prospect within the Yalgoo Project, aiming to unlock the potential of a highly prospective 5 square kilometre mineralised zone.

Moho Resources is accelerating drilling at its Bush Chook Project in WA’s Pilbara, focusing on the promising Emu and Little Creature gold prospects after recent tenement grants.

SQX Resources has launched its first-ever reverse circulation drilling campaign at the Red Bird Gold Project in Arizona, aiming to unlock high-grade gold potential validated by recent sampling.

Biome Australia has secured ethics approval to commence a pivotal human clinical trial of its proprietary probiotic strain BMB18, aiming to validate its benefits on digestive, sleep, and mood health.